# FDA Inspection 621577 - Glaxo Operations UK Limited - July 21, 2009

Source: https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-limited/f41cacd2-83d7-45fe-89e8-1649fd5b392e
Source feed: FDA_Inspections

> FDA Inspection 621577 for Glaxo Operations UK Limited on July 21, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 621577
- Company Name: Glaxo Operations UK Limited
- Inspection Date: 2009-07-21
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1267917 - 2024-12-06](https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-limited/97bdbdb0-0b59-4a10-a82a-7be4ddb0a48e)
- [FDA Inspection 1267917 - 2024-12-06](https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-limited/866d1de5-36a3-4b93-b9b1-03b8da321d62)
- [FDA Inspection 1102175 - 2019-09-06](https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-limited/93a229ee-cd04-416d-8be7-71aad893fb17)
- [FDA Inspection 1099616 - 2019-01-25](https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-limited/83734ddd-d145-491e-a432-28b35be90c35)
- [FDA Inspection 935343 - 2015-07-10](https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-limited/f370750b-f287-4d45-a7f8-3c4d61764588)

Company: https://www.keypedia.com/companies/glaxo-operations-uk-limited/203ed5e0-7ae4-490f-b37a-9293e17eae84

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c